Qoly

Qoly is focused on the development, manufacturing, and support of robots designed for microsurgery, a highly specialized field of surgery that involves operating on minute structures like thin blood vessels, nerves, and lymphatic vessels under a microscope. These procedures demand exceptional skill and experience, and the number of surgeons capable of performing them is limited. Qoly's technology aims to democratize this expertise by providing robotic assistance that enhances the precision and safety of these complex operations. One of the core features of its system is a "motion scale function," which reduces the surgeon's hand movements at a scale of 1/2 to 1/10, facilitating the delicate suturing of vessels and nerves as small as 0.3mm to 0.8mm in diameter. This technology is inherited from medical robot research conducted within the Sony Group.

In February 2026, Qoly announced it had raised $11.5 million (¥1.8 billion) in a Series A funding round. The round was led by Fast Track Initiative and MedVenture Partners, with participation from Sony Group Corporation and the Development Bank of Japan. This capital is intended to accelerate the product and solution development of its microsurgery support robot to achieve practical clinical use and contribute to a sustainable medical system. The company is currently generating revenue and moving towards the social implementation of its technology.